SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options
- PMID: 32329877
- DOI: 10.26355/eurrev_202004_20871
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options
Abstract
SARS-CoV-2 is responsible for the outbreak of severe respiratory illness (COVID-19) in Wuhan City, China and is now spreading rapidly throughout the world. The prompt outbreak of COVID-19 and its quick spread without any controllable measure defines the severity of the situation. In this crisis, a collective pool of knowledge about the advancement of clinical diagnostic and management for COVID-19 is a prerequisite. Here, we summarize all the available updates on the multidisciplinary approaches for the advancement of diagnosis and proposed therapeutic strategies for COVID-19. Moreover, the review discusses different aspects of the COVID-19, including its epidemiology; incubation period; the general clinical features of patients; the clinical features of intensive care unit (ICU) patients; SARS-CoV-2 infection in the presence of co-morbid diseases and the clinical features of pediatric patients infected with the SARS-CoV-2. Advances in various diagnostic approaches, such as the use of real-time polymerase chain reaction (RT-PCR), chest radiography, and computed tomography (CT) imaging; and other modern diagnostic methods, for this infection have been highlighted. However, due to the unavailability of adequate evidence, presently there are no officially approved drugs or vaccines available against SARS-CoV-2. Additionally, we have discussed various therapeutic strategies for COVID-19 under different categories, like the possible treatment plans with drug (antiviral drugs and anti-cytokines) therapy for disease prevention. Lastly, potentials candidates for the vaccines against SARS-CoV-2 infection have been described. Collectively, the review provides an overview of the SARS-CoV-2 infection outbreak along with the recent advancements and strategies for diagnosis and therapy of COVID-19.
Similar articles
-
COVID-19: Main therapeutic options.Tunis Med. 2020 Apr;98(4):299-303. Tunis Med. 2020. PMID: 32395792 Review. No abstract available.
-
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011. J Microbiol Biotechnol. 2020. PMID: 32238757 Free PMC article. Review.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
-
SARS-CoV-2; What We Know so far.Arch Iran Med. 2020 Jul 1;23(7):498-502. doi: 10.34172/aim.2020.47. Arch Iran Med. 2020. PMID: 32657601 Review.
-
A Review of SARS-CoV-2 and the Ongoing Clinical Trials.Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657. Int J Mol Sci. 2020. PMID: 32290293 Free PMC article. Review.
Cited by
-
Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review).Exp Ther Med. 2021 Apr;21(4):320. doi: 10.3892/etm.2021.9751. Epub 2021 Feb 3. Exp Ther Med. 2021. PMID: 33732293 Free PMC article. Review.
-
The management of patients with coronavirus disease 2019 in intensive care unit (ICU) in low income countries: A review article.Clin Nutr Open Sci. 2021 Jun;37:60-72. doi: 10.1016/j.nutos.2021.05.001. Epub 2021 May 23. Clin Nutr Open Sci. 2021. PMID: 34056632 Free PMC article. Review.
-
Human/SARS-CoV-2 genome-scale metabolic modeling to discover potential antiviral targets for COVID-19.J Taiwan Inst Chem Eng. 2022 Apr;133:104273. doi: 10.1016/j.jtice.2022.104273. Epub 2022 Feb 15. J Taiwan Inst Chem Eng. 2022. PMID: 35186172 Free PMC article.
-
A novel ensemble fuzzy classification model in SARS-CoV-2 B-cell epitope identification for development of protein-based vaccine.Appl Soft Comput. 2022 Feb;116:108280. doi: 10.1016/j.asoc.2021.108280. Epub 2021 Dec 15. Appl Soft Comput. 2022. PMID: 34931117 Free PMC article.
-
Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?Front Oncol. 2022 May 6;12:871132. doi: 10.3389/fonc.2022.871132. eCollection 2022. Front Oncol. 2022. PMID: 35600364 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous